Re: New shares issued?
in response to
by
posted on
Aug 14, 2018 01:56PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Thanks BDAZ
Yes I agree and, from my point of view, if ZCC sells off ZEL it is probably the best scenario.
I remember reading that DM in a small conversation mentionned that that if ZEL is sold some money would come to ZCC shareholders, likely as a dividend, and some shareholders would likely reinvest those proceeds in RVX.
I believe that would probably be via a dividend paid to all ZCC shareholders and that would also be fine with me. I hold my Zenith shares in a TFSA so there would not be any tax implications to me and I would be one who would turn around and buy shares of RVX in my TFSA for the full value of any dividend received in my TFSA.
I was making the point that insiders in ZCC, or other large investors in the PP, were investing more of their cash in ZCC at a price of $2.60 per share and that in my opinion the real value of ZCC shares was at least $2.60 rather than the value it shows as in my brokerage account of $0.659
If the BOD decides to go public as ZCC that is also good with me since the increase in share value from when ZCC was split off would be available to me from my TFSA at any time if I decided to sell, with again no tax consequences; although I believe that I would not sell but retain the increased value within my TFSA
Regards